சூசன் புக்கேனோ News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The data are based on the inoculation of more than 10 million people in Chile. However, despite having vaccinated more than 70% of its population, the country seeing an increase in cases. The CoronaVac vaccine is 66% effective at preventing symptomatic Covid-19 infection among fully vaccinated adults aged 16 years and older, according to a real-world study published on 7 July in  The more promising finding, however, was that the two-dose vaccine showed higher protection against hospitalisation (87.5%), ICU admission (90%); and death (86%) – a finding that is consistent with the results of Phase 2 trials of the vaccine, the researchers said. Chile’s vaccination programme kicked off on 2 February 2021, and the study was conducted from February through May 2021. It evaluated the effect of the jab in approximately 10.2 million fully immunised Chileans.

United kingdomSouth africaSusan buenoMichael touchtonLiu peichengAfrican health products regulatory authority sahpraPontifical catholic universityWorld health organisationNew england journalBritish medical journalஒன்றுபட்டது கிஂக்டம்சூசன் புக்கேனோமைக்கேல் டச்ச்டன்பாஂடிஃபிகல் கத்தோலிக் பல்கலைக்கழகம்உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந்புதியது இங்கிலாந்து இதழ்